 |
The human epidermal growth factor receptor (HER) family has four receptors: HER1(EGFR), HER2, HER3 and HER4. These receptors and their associated signaling pathways have been the focus of research and development of targeted therapies. |
Biologics such as erlotinib, lapatinib and trastuzumab were developed as a result of this research. Many of these targeted therapies use diagnostic tests to identify the best patients for the treatment.
| Monogram's VeraTag is a proximity-based technology platform designed to detect and quantify proteins and protein-protein complexes, including homodimers and heterodimers of the HER family of cell-surface receptors. |  |
